RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Magaly Martinez-Ferrer to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Magaly Martinez-Ferrer has written about Antineoplastic Agents.
Magaly Martinez-Ferrer
Connection Strength
0.198
Antineoplastic Agents
  1. Ocasio-Malav? C, Donate MJ, S?nchez MM, Sosa-Rivera JM, Mooney JW, Pereles-De Le?n TA, Carballeira NM, Zayas B, V?lez-Gerena CE, Mart?nez-Ferrer M, Sanabria-R?os DJ. Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells. Bioorg Med Chem Lett. 2020 01 01; 30(1):126760.
    View in: PubMed
    Score: 0.103
  2. Goldsmith ZK, Coppess W, Irvine AS, Yuan K, Barsh SR, Ritter MK, McEwen MW, Flores-Otero J, Garcia-Vargas A, Martinez-Ferrer M, Brennan RC, Morales-Tirado VM, Wilson MW. Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds. Invest Ophthalmol Vis Sci. 2018 09 04; 59(11):4486-4495.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support